Literature DB >> 28134012

Treatment of Epileptic Encephalopathies: Current State of the Art.

Hiroki Nariai1, Susan Duberstein1,2, Shlomo Shinnar1,2,3.   

Abstract

Childhood epileptic encephalopathies are age-dependent disorders of the brain whose hallmarks include loss of neurologic function over time, abnormal electroencephalographic findings, and seizures. Ictal and interictal electrographic activity are conjointly thought to be at the root of the often devastating neuropsychological deterioration, which is specific to the maturing brain. The goals of treatment are not only to control seizures, but also to prevent or reverse neurologic loss of function. In general, time is of the essence in diagnosis, and experienced specialists should promptly design a treatment plan. Hormonal and immune therapies are at the forefront of treatment in many cases, with traditional antiepileptic drugs and surgery (when an identifiable lesion is present) playing a limited role. However, gold standard evidence for treatment of epileptic encephalopathies remains limited. Ongoing clinical and basic research may lead to better understanding of these catastrophic conditions and to better and more effective therapies.

Entities:  

Keywords:  abnormal interictal EEG; cognitive outcome; hormonal therapy; immune therapy; intractable seizures

Mesh:

Year:  2017        PMID: 28134012      PMCID: PMC5494023          DOI: 10.1177/0883073817690290

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  94 in total

1.  Efficacy of intravenous immunoglobulin in Landau-Kleffner syndrome.

Authors:  Mohamad A Mikati; Raya Saab; Michel N Fayad; Roula N Choueiri
Journal:  Pediatr Neurol       Date:  2002-04       Impact factor: 3.372

Review 2.  Medical versus surgical treatment: which treatment when.

Authors:  W Donald Shields
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

Review 3.  Callosotomy for intractable epilepsy: overall outcome.

Authors:  A Rougier; B Claverie; J M Pedespan; C Marchal; P Loiseau
Journal:  J Neurosurg Sci       Date:  1997-03       Impact factor: 2.279

4.  Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial.

Authors:  A Marson; A Jacoby; A Johnson; L Kim; C Gamble; D Chadwick
Journal:  Lancet       Date:  2005 Jun 11-17       Impact factor: 79.321

5.  A prospective study of infantile spasms: clinical and therapeutic correlations.

Authors:  C T Lombroso
Journal:  Epilepsia       Date:  1983-04       Impact factor: 5.864

Review 6.  Treatment of infantile spasms: emerging insights from clinical and basic science perspectives.

Authors:  Carl E Stafstrom; Barry G W Arnason; Tallie Z Baram; Anna Catania; Miguel A Cortez; Tracy A Glauser; Michael R Pranzatelli; Raili Riikonen; Michael A Rogawski; Shlomo Shinnar; John W Swann
Journal:  J Child Neurol       Date:  2011-06-30       Impact factor: 1.987

Review 7.  Epidemiological data of West syndrome in Finland.

Authors:  R Riikonen
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

8.  Corpus callosotomy for medically intractable seizures.

Authors:  J M Sorenson; J W Wheless; J E Baumgartner; A B Thomas; B L Brookshire; G L Clifton; L J Willmore
Journal:  Pediatr Neurosurg       Date:  1997-11       Impact factor: 1.162

9.  A role of autoimmunity in the etiopathogenesis of Landau-Kleffner syndrome?

Authors:  S Nevsímalová; A Tauberová; S Doutlík; V Kucera; O Dlouhá
Journal:  Brain Dev       Date:  1992-09       Impact factor: 1.961

10.  Atypical rolandic epilepsy.

Authors:  Natalio Fejerman
Journal:  Epilepsia       Date:  2009-08       Impact factor: 5.864

View more
  6 in total

1.  Drug refractory epilepsy in children: many concerns!

Authors:  Indar Kumar Sharawat; Lesa Dawman
Journal:  Childs Nerv Syst       Date:  2019-05-06       Impact factor: 1.475

Review 2.  Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.

Authors:  Adam Strzelczyk; Susanne Schubert-Bast
Journal:  CNS Drugs       Date:  2021-01-21       Impact factor: 5.749

3.  Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers.

Authors:  Shining Wang; Grace Chen; Emilio Merlo Pich; John Affinito; Michael Cwik; Hélène M Faessel
Journal:  Br J Clin Pharmacol       Date:  2022-01-31       Impact factor: 3.716

4.  An epilepsy-associated ACTL6B variant captures neuronal hyperexcitability in a human induced pluripotent stem cell model.

Authors:  Lucie Y Ahn; Giuliana C Coatti; Jingyi Liu; Evren Gumus; Ashleigh E Schaffer; Helen C Miranda
Journal:  J Neurosci Res       Date:  2020-11-03       Impact factor: 4.164

Review 5.  Treatment of Focal-Onset Seizures in Children: Should This Be More Etiology-Driven?

Authors:  Alec Aeby; Berten Ceulemans; Lieven Lagae
Journal:  Front Neurol       Date:  2022-03-07       Impact factor: 4.003

Review 6.  Rare, epilepsy-related disorder including intellectual disability - A scoping review of caregivers' identified information needs.

Authors:  Merete Kristin Tschamper; Silje Systad
Journal:  J Intellect Disabil       Date:  2021-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.